Table 3 Multivariate cox-regression model for patients after primary surgery and neoadjuvnat treatment.

From: Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival

 

Primary surgery

Neoadjuvant treatment

Hazard ratio

95% confidence interval

p value

Hazard ratio

95% confidence interval

p value

Lower

Upper

Lower

Upper

Sex (male vs. female)

0.74

0.37

1.48

0.394

1.372

0.797

2.361

0.254

Age group (< 65yrs vs. > 65 yrs)

1.537

1.011

2.339

0.044

1.319

0.953

1.825

0.095

Tumor stage (pT1/2 vs. pT3/4)

2.057

1.208

3.504

0.008

0.922

0.593

1.433

0.718

Lymph node metastasis (pN0 vs. pN +)

3.641

2.228

5.951

< 0.001

2.571

1.771

3.732

< 0.001

Integrin alphaV expression (negative vs. positive)

2.031

1.102

3.741

0.023

0.951

0.618

1.464

0.819

Back to article page